The impact of diagnosis and trait anxiety on psychological distress in women with early stage breast cancer: A prospective study

C.M.G. Keyzer-Dekker, J. de Vries, M.C. Mertens, J.A. Roukema, A.F.W. van der Steeg

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Objectives
High trait anxiety (HTA) determines depressive symptoms and state anxiety in women with breast cancer (BC) or benign breast disease (BBD). Before implementing screening for psychological counselling in these women, it is important to evaluate whether high state anxiety and depressive symptoms are determined by (the threat of) having BC or solely by HTA. Therefore, we compared women with a lump in the breast with women with gallstone disease (GD).
Methods
Women diagnosed with BC (n = 152), BBD (n = 205), and GD (n = 128) were included in a prospective longitudinal study. Questionnaires concerning trait anxiety (baseline), state anxiety, and depressive symptoms were completed before diagnosis was known (BC and BBD) or the laparoscopic cholecystectomy and 6 months later.
Results
Pre‐diagnosis BC patients scored higher on state anxiety (p = .001) and depressive symptoms (p < .001) compared with GD. At 6 months, scores on depressive symptoms in BC remained higher than GD (p = .005). In women with HTA, before being diagnosed with BC or BBD, scores on state anxiety were higher compared with HTA women with GD (p < .001, p = .040). State anxiety and depressive symptoms at 6 months were predicted by baseline depressive symptoms in women with BC.
Conclusions
The severity of diagnosis (BC) in combination with HTA determined the level of state anxiety and depressive symptoms. Therefore, we recommend identifying women with HTA and offering them a tailor‐made follow‐up protocol during and after the diagnostic process for BBD or BC.
Original languageEnglish
Pages (from-to)783-794
JournalBritish Journal of Health Psychology
Volume19
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Depression
Gallstones
Laparoscopic Cholecystectomy

Cite this

@article{7353a9a4d0fb4ad9956513a6200d14d9,
title = "The impact of diagnosis and trait anxiety on psychological distress in women with early stage breast cancer: A prospective study",
abstract = "ObjectivesHigh trait anxiety (HTA) determines depressive symptoms and state anxiety in women with breast cancer (BC) or benign breast disease (BBD). Before implementing screening for psychological counselling in these women, it is important to evaluate whether high state anxiety and depressive symptoms are determined by (the threat of) having BC or solely by HTA. Therefore, we compared women with a lump in the breast with women with gallstone disease (GD).MethodsWomen diagnosed with BC (n = 152), BBD (n = 205), and GD (n = 128) were included in a prospective longitudinal study. Questionnaires concerning trait anxiety (baseline), state anxiety, and depressive symptoms were completed before diagnosis was known (BC and BBD) or the laparoscopic cholecystectomy and 6 months later.ResultsPre‐diagnosis BC patients scored higher on state anxiety (p = .001) and depressive symptoms (p < .001) compared with GD. At 6 months, scores on depressive symptoms in BC remained higher than GD (p = .005). In women with HTA, before being diagnosed with BC or BBD, scores on state anxiety were higher compared with HTA women with GD (p < .001, p = .040). State anxiety and depressive symptoms at 6 months were predicted by baseline depressive symptoms in women with BC.ConclusionsThe severity of diagnosis (BC) in combination with HTA determined the level of state anxiety and depressive symptoms. Therefore, we recommend identifying women with HTA and offering them a tailor‐made follow‐up protocol during and after the diagnostic process for BBD or BC.",
author = "C.M.G. Keyzer-Dekker and {de Vries}, J. and M.C. Mertens and J.A. Roukema and {van der Steeg}, A.F.W.",
year = "2014",
doi = "10.1111/bjhp.12076",
language = "English",
volume = "19",
pages = "783--794",
journal = "British Journal of Health Psychology",
issn = "1359-107X",
publisher = "Wiley-Blackwell",
number = "4",

}

The impact of diagnosis and trait anxiety on psychological distress in women with early stage breast cancer : A prospective study. / Keyzer-Dekker, C.M.G.; de Vries, J.; Mertens, M.C.; Roukema, J.A.; van der Steeg, A.F.W.

In: British Journal of Health Psychology, Vol. 19, No. 4, 2014, p. 783-794.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - The impact of diagnosis and trait anxiety on psychological distress in women with early stage breast cancer

T2 - A prospective study

AU - Keyzer-Dekker, C.M.G.

AU - de Vries, J.

AU - Mertens, M.C.

AU - Roukema, J.A.

AU - van der Steeg, A.F.W.

PY - 2014

Y1 - 2014

N2 - ObjectivesHigh trait anxiety (HTA) determines depressive symptoms and state anxiety in women with breast cancer (BC) or benign breast disease (BBD). Before implementing screening for psychological counselling in these women, it is important to evaluate whether high state anxiety and depressive symptoms are determined by (the threat of) having BC or solely by HTA. Therefore, we compared women with a lump in the breast with women with gallstone disease (GD).MethodsWomen diagnosed with BC (n = 152), BBD (n = 205), and GD (n = 128) were included in a prospective longitudinal study. Questionnaires concerning trait anxiety (baseline), state anxiety, and depressive symptoms were completed before diagnosis was known (BC and BBD) or the laparoscopic cholecystectomy and 6 months later.ResultsPre‐diagnosis BC patients scored higher on state anxiety (p = .001) and depressive symptoms (p < .001) compared with GD. At 6 months, scores on depressive symptoms in BC remained higher than GD (p = .005). In women with HTA, before being diagnosed with BC or BBD, scores on state anxiety were higher compared with HTA women with GD (p < .001, p = .040). State anxiety and depressive symptoms at 6 months were predicted by baseline depressive symptoms in women with BC.ConclusionsThe severity of diagnosis (BC) in combination with HTA determined the level of state anxiety and depressive symptoms. Therefore, we recommend identifying women with HTA and offering them a tailor‐made follow‐up protocol during and after the diagnostic process for BBD or BC.

AB - ObjectivesHigh trait anxiety (HTA) determines depressive symptoms and state anxiety in women with breast cancer (BC) or benign breast disease (BBD). Before implementing screening for psychological counselling in these women, it is important to evaluate whether high state anxiety and depressive symptoms are determined by (the threat of) having BC or solely by HTA. Therefore, we compared women with a lump in the breast with women with gallstone disease (GD).MethodsWomen diagnosed with BC (n = 152), BBD (n = 205), and GD (n = 128) were included in a prospective longitudinal study. Questionnaires concerning trait anxiety (baseline), state anxiety, and depressive symptoms were completed before diagnosis was known (BC and BBD) or the laparoscopic cholecystectomy and 6 months later.ResultsPre‐diagnosis BC patients scored higher on state anxiety (p = .001) and depressive symptoms (p < .001) compared with GD. At 6 months, scores on depressive symptoms in BC remained higher than GD (p = .005). In women with HTA, before being diagnosed with BC or BBD, scores on state anxiety were higher compared with HTA women with GD (p < .001, p = .040). State anxiety and depressive symptoms at 6 months were predicted by baseline depressive symptoms in women with BC.ConclusionsThe severity of diagnosis (BC) in combination with HTA determined the level of state anxiety and depressive symptoms. Therefore, we recommend identifying women with HTA and offering them a tailor‐made follow‐up protocol during and after the diagnostic process for BBD or BC.

U2 - 10.1111/bjhp.12076

DO - 10.1111/bjhp.12076

M3 - Article

VL - 19

SP - 783

EP - 794

JO - British Journal of Health Psychology

JF - British Journal of Health Psychology

SN - 1359-107X

IS - 4

ER -